PPARG and hepatocellular carcinoma: Moreover, we analyzed triple correlation of USP22/PPARG/ACACA (or ACLY) and found that simultaneously high expression levels of USP22/PPARG/ACACA (or ACLY) had worse overall survival in HCC cohorts (Supplementary Fig. 8e).